Financials

News Ideas Discussions Technicals Forecast Seasonals

NEU fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to NEUREN PHARMACEUTICALS LIMITED operating, investing, and financing activities

NEU free cash flow for H2 24 is 9.26 M AUD. For 2024, NEU free cash flow was -11.28 M AUD and operating cash flow was -11.27 M AUD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: AUD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—